Caribou Biosciences, Inc. · NASDAQ:CRBU
The Vanguard Group's stake in Caribou Biosciences, Inc. fell to 4.86% (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 30, 2025
The Vanguard Group's stake in Caribou Biosciences, Inc. fell to 4.86%, 4,522,032 shares, as a passive investor on Mar 31, 2025. Filed Apr 30, 2025 (Schedule 13G/A).
- Stake
- 4.86%
- Shares
- 4,522,032
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 4.86% | 4,522,032 |
Source
Related
- Caribou Biosciences, Inc.
- The Vanguard Group
- Caribou Biosciences, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 16, 2025
- Schedule 13D · Rachel E. Haurwitz · Apr 25, 2025
- Schedule 13G/A · BlackRock, Inc. · Apr 17, 2025
- Schedule 13G/A · Bank of America Corp · Feb 14, 2025